CIK 1560009

Versant Venture Management, LLC

Institutional 13F holdings & portfolio

Holdings

Portfolio Value

$1M+

Latest Report

Dec 31, 2025

Report Periods

Holdings

13F filings as of Dec 31, 2025 · Showing 1–7 of 7

Ticker	Company	Shares	Value	Type
GLUE	Monte Rosa Therapeutics, Inc.	4.4M	$1M+	SH
LENZ	Lenz Therapeutics, Inc.	2.7M	$1M+	SH
JBIO	Jade Biosciences, Inc.	1.5M	$1M+	SH
CRSP	CRISPR Therapeutics AG	149K	$1M+	SH
CTNM	Contineum Therapeutics, Inc.	543K	$1M+	SH
SKYE	Skye Bioscience, Inc.	2.0M	$1M+	SH
TPST	Tempest Therapeutics, Inc.	270K	$500K+	SH